维普中文期刊产品整合服务
45篇 您的检索式:作者名="Foster NR"
    题名 作者 年代 出处 被引量
1相对于男性,女性进行冠状动脉造影产生的额外的心血管病风险与严重受损的冠状动脉血流储备,而非阻塞性疾病相关显示文摘与男性相比,女性的心血管病死亡率更高,但是阻塞性冠状动脉疾病(coronary artery disease,CAD)在女性中不太普遍。冠状动脉血流储备(coronary flow reserve,CFR)是大、小血管CAD和心肌缺血的综合测量指标,可识别出具有心血管病死亡风险的患者,但其在临床实践中不是常规测量的指标。该研究试图调查性别、CFR和血管造影CAD严重程度对不良心血管事件的影响。刘莉 叶鹏 Taqueti VR Shaw LJ Cook NR Murthy VL Shah NR Foster CR Hainer J Blankstein R Dorbala S Di Carli MF 2016中华高血压杂志2016,24,11:2
2Oxaliplatin and capecitabine inpatients with metastatic adenocarcinoma of the esophagus, gastroesophgealjunction and gastric cardia: a phase Ⅱ study from thenorth central cancer treatment group 显示文摘Jatoi A Murphy B Foster NR 2006Ann Oncol2006,17,1:1
3Prognostic factors dif- fer by tumor stage for small cell lung cancer:a pooled analysis of North Central Cancer Treatment Group trials显示文摘Foster NR Mandrekar SJ Schild SE 2009Cancer2009,115,12:1
4Phase I trial of a pathotropic retroviral vector expressing a eytocidal cyclin GI construct (Rexin-G)in patients with advanced pancreatic cancer显示文摘Galanis E Carlson SK Foster NR 2008Mol Ther2008,16,:1
5Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials 显示文摘Foster NR Mandrekar SJ Schild SE 2009Cancer2009,115,12:1
6Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NccrG) phase I and II trial,N9943显示文摘Alberts SR Sande JR Foster NR 2007J Gastroin?test Cancer2007,38,24:1
7Randomized phase Ⅱ trial of panitumumab, erlotinib, and gemcitabine (PGE) versuserlotinib-gemcitabine (GE) in patients with untreated, metastatic pancreatic adenocarcinoma显示文摘KIM GP FOSTER NR SALIM M 2011J Clin Oncol2011,,:1
8Conventional and de- nse gas techniques for the production of liposomes: a re- view显示文摘Meure LA Foster NR Dehghani F 2008AAPS PharmSciTech2008,9,3:1
9Oxaliplatin and capecitabine in patients with metastatic adenoearcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase Ⅱ study from the North Central Cancer Treatment Group显示文摘Jatoi A Murphy BR Foster NR 2006Ann Oncol2006,17,1:1
10Prophylactic cranial ir- radiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis显示文摘Schild SE1 Foster NR Meyers JP 2012Ann Oncol2012,23,:1
11Prognostic effect of acti- vated EGFR expression in human colon carcinomas; comparison with EGFR status显示文摘Rego RL Foster NR Smyrk TC 2010Br J Cancer2010,102,1:1
12Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin 显示文摘Charoenchaitrakool M Dehghani F Foster NR 2002Int J Pharm2002,239,12:1
13Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials 显示文摘Sinicrope FA Foster NR Yoon H H 2012J Clin Oncol2012,30,4:1
14Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer显示文摘Galanis E Carlson SK Foster NR 2008Mol Ther2008,16,5:1
15Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials显示文摘Sinicrope FA Foster NR Yoon HR 2012J Clin Oncol2012,30,4:1
16Obesity is an independent prognostic variable in colon cancer survivors 显示文摘Sinicrope FA Foster NR Sargent DJ 2010Clin Cancer Res2010,16,30:1
17Prognostic effect of activated EGFR expression in human colon carcinomas:comparison with EG- FR status显示文摘Rego RL Foster NR Smyrk TC 2010Br J Cancer2010,102,1:1
18PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase Ⅱ study 显示文摘Alberts SR Foster NR Morton RF 2005Ann Oncol2005,16,10:1
19Micronization of copper indomethacin using gas antisolvent processes显示文摘Warwick B Dehghani F Foster NR 2002Ind Eng Chem Res2002,41,:1
20Prognostic impact of FoxP3 + regulatory T cells in relation to CD8 + T lymphocyte density in human colon carcinomas显示文摘Yoon HH Orrock JM Foster NR 0,,8:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费